IBO (STOCKS)
Impact BioMedical, Inc.
$0.654000
-0.033800 (-4.91%)
Prev close: $0.687800
Company Information
- Exchange
- XASE
- Sector
- Electronic Technology
- Industry
- Electronic Equipment/Instruments
- CEO
- Frank D. Heuszel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $73.86M
- Employees
- 8
- P/E (TTM)
- -0.51
- P/B (TTM)
- 5.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Selling, General, and Administrative Expenses | $873.00K |
| Depreciation and Amortization | $1.15M |
| Research and Development | $340.00K |
| Operating Income/Loss | -$4.28M |
| Income/Loss From Continuing Operations After Tax | -$11.87M |
| Income/Loss From Continuing Operations Before Tax | -$14.45M |
| Income Tax Expense/Benefit | -$2.58M |
| Income Tax Expense/Benefit, Deferred | -$2.58M |
| Interest Expense, Operating | $793.00K |
| Net Income/Loss | -$11.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$32.00K |
| Net Income/Loss Attributable To Parent | -$11.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.38 |
| Diluted Earnings Per Share | -$0.38 |
| Basic Average Shares | 31,550,457 |
| Assets | $17.41M |
| Current Assets | $411.00K |
| Prepaid Expenses | $142.00K |
| Other Current Assets | $269.00K |
| Noncurrent Assets | $16.99M |
| Liabilities | $1.85M |
| Current Liabilities | $1.16M |
| Accounts Payable | $347.00K |
| Other Current Liabilities | $815.00K |
| Noncurrent Liabilities | $688.00K |
| Equity | $15.56M |
| Equity Attributable To Noncontrolling Interest | $2.95M |
| Equity Attributable To Parent | $12.61M |
| Liabilities And Equity | $17.41M |
| Net Cash Flow From Operating Activities | -$1.89M |
| Net Cash Flow From Operating Activities, Continuing | -$1.89M |
| Net Cash Flow From Investing Activities | $3.00K |
| Net Cash Flow From Investing Activities, Continuing | $3.00K |
| Net Cash Flow From Financing Activities | -$109.00K |
| Net Cash Flow From Financing Activities, Continuing | -$109.00K |
| Net Cash Flow | -$2.00M |
| Net Cash Flow, Continuing | -$2.00M |
| Comprehensive Income/Loss | -$11.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.87M |
| Other Comprehensive Income/Loss | $0.00 |